中国中西医结合急救杂志
中國中西醫結閤急救雜誌
중국중서의결합급구잡지
INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE IN PRACTICE OF CRITICAL CARE MEDICINE
2012年
6期
352-354
,共3页
王艳飞%曹雪滨%任越%王红英%王裕勤%李雪蛟%何建成
王豔飛%曹雪濱%任越%王紅英%王裕勤%李雪蛟%何建成
왕염비%조설빈%임월%왕홍영%왕유근%리설교%하건성
压力负荷%卡托普利%心力衰竭%细胞凋亡%治疗
壓力負荷%卡託普利%心力衰竭%細胞凋亡%治療
압력부하%잡탁보리%심력쇠갈%세포조망%치료
Pressure overload%Captopril%Heart failure%Cardiomyocyte apoptosis%Therpy
目的探讨卡托普利对慢性压力负荷性心力衰竭(心衰)大鼠心肌细胞凋亡的影响.方法选择90只 SD 大鼠,按随机数字表法分为假手术组、模型组、卡托普利组.采用腹主动脉缩窄法复制慢性压力负荷性心衰大鼠模型,分别于药物干预6周(每组10只)、10周时(3组分别存活11、12、13只)应用流式细胞仪测定各组大鼠心肌细胞凋亡率.结果假手术组和模型组10周时细胞凋亡率与6周时比较差异均无统计学意义(均 P>0.05),卡托普利组10周时较6周明显降低〔(4.79±0.61)%比(6.80±0.89)%,P<0.01〕;模型组、卡托普利组药物干预6周、10周时心肌细胞凋亡率均明显升高,与假手术组同期比较差异均有统计学意义〔6周:(10.08±0.95)%、(6.80±0.89)%比(2.45±0.44)%,10周:(10.60±0.65)%、(4.79±0.61)%比(2.62±0.45)%,均 P<0.01〕;卡托普利组心肌细胞凋亡率明显下降,与模型组同期比较差异均有统计学意义(均 P<0.01).结论卡托普利能减少心肌细胞的凋亡,从而改善充血性心衰大鼠的心脏功能.
目的探討卡託普利對慢性壓力負荷性心力衰竭(心衰)大鼠心肌細胞凋亡的影響.方法選擇90隻 SD 大鼠,按隨機數字錶法分為假手術組、模型組、卡託普利組.採用腹主動脈縮窄法複製慢性壓力負荷性心衰大鼠模型,分彆于藥物榦預6週(每組10隻)、10週時(3組分彆存活11、12、13隻)應用流式細胞儀測定各組大鼠心肌細胞凋亡率.結果假手術組和模型組10週時細胞凋亡率與6週時比較差異均無統計學意義(均 P>0.05),卡託普利組10週時較6週明顯降低〔(4.79±0.61)%比(6.80±0.89)%,P<0.01〕;模型組、卡託普利組藥物榦預6週、10週時心肌細胞凋亡率均明顯升高,與假手術組同期比較差異均有統計學意義〔6週:(10.08±0.95)%、(6.80±0.89)%比(2.45±0.44)%,10週:(10.60±0.65)%、(4.79±0.61)%比(2.62±0.45)%,均 P<0.01〕;卡託普利組心肌細胞凋亡率明顯下降,與模型組同期比較差異均有統計學意義(均 P<0.01).結論卡託普利能減少心肌細胞的凋亡,從而改善充血性心衰大鼠的心髒功能.
목적탐토잡탁보리대만성압력부하성심력쇠갈(심쇠)대서심기세포조망적영향.방법선택90지 SD 대서,안수궤수자표법분위가수술조、모형조、잡탁보리조.채용복주동맥축착법복제만성압력부하성심쇠대서모형,분별우약물간예6주(매조10지)、10주시(3조분별존활11、12、13지)응용류식세포의측정각조대서심기세포조망솔.결과가수술조화모형조10주시세포조망솔여6주시비교차이균무통계학의의(균 P>0.05),잡탁보리조10주시교6주명현강저〔(4.79±0.61)%비(6.80±0.89)%,P<0.01〕;모형조、잡탁보리조약물간예6주、10주시심기세포조망솔균명현승고,여가수술조동기비교차이균유통계학의의〔6주:(10.08±0.95)%、(6.80±0.89)%비(2.45±0.44)%,10주:(10.60±0.65)%、(4.79±0.61)%비(2.62±0.45)%,균 P<0.01〕;잡탁보리조심기세포조망솔명현하강,여모형조동기비교차이균유통계학의의(균 P<0.01).결론잡탁보리능감소심기세포적조망,종이개선충혈성심쇠대서적심장공능.
Objective To test the effects of captopril on cardiomyocyte apoptosis in rats with chronic pressure overloaded heart failure. Methods A total of 90 Sprague-Dawley(SD)rats were randomly divided into three groups :sham operation group,model group and captopril treatment group. The models of rats were established by constricting the abdominal aorta partly. The rate of cardiomyocyte apoptosis in each group was respectively measured by flow cytometry 6 weeks(each,n =10)and 10 weeks(n =11,12,13 in the three groups,respectively)after medicine intervention. Results In either the sham operation group or the model group,the rates of cardiomyocyte apoptosis at the time points of 6 and 10 weeks had no statistically significant difference from each other(both P>0.05). However,the rate of captopril treatment group was decreased obviously in 10 weeks compared with that in 6 weeks 〔(4.79±0.61)% vs. (6.80±0.89)%,P<0.01〕. The cardiomyocte apoptosis rates in model and captopril treatment groups were markedly increased compared with those at the same time in the sham operation group〔6 weeks :(10.08±0.95)%,(6.80±0.89)% vs.(2.45±0.44)% ;10 weeks :(10.60±0.65)%,(4.79±0.61)%vs.(2.62±0.45)%,all P<0.01〕. The rates of apoptosis in captopril treatment group were declined sharply compared with those at the same time in the model group in 6 weeks and 10 weeks(both P<0.01). Conclusion Captopril can decrease the cardiomyocyte apoptosis and improve the myocardial function in rats with congestive heart failure.